BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Orphazyme A/S: New Share-Based Incentive Programme

  Orphazyme has today implemented a new long-term incentive programme.

  November 16, 2017

   · 

  4 min read
• Pharm Country

  Intact Vascular: Positive Twenty-Four Month Tack Optimized Balloon Angioplasty (“TOBA”) Single Center Results Presented at VEITHsymposium Conference

  The TOBA study enrolled 138 subjects at 13 sites in Europe.

  November 16, 2017

   · 

  3 min read
• Genetown

  Alnylam Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

  The aggregate gross proceeds to Alnylam from the offering, before deducting the underwriting discounts and commissions and other estimated offering expenses, are expected to be $805 million.

  November 16, 2017

   · 

  5 min read
• Business

  David C. Pacitti Joins Apollo Endosurgery Board of Directors

  He will commence service on December 8, 2017.

  November 16, 2017

   · 

  2 min read
• 

  Business

  Oncolytics Biotech, Adlai Nortye Forge $86.6M Reolysin Deal

  Under the terms of The Agreement, Adlai will have exclusive development and commercialization rights to REOLYSIN in China, Hong Kong, Macau, Singapore, South Korea and Taiwan.

  November 16, 2017

   · 

  8 min read
• Array BioPharma Announces Private Exchange of $107M of its 3.00% Convertible Senior Notes Due 2020 for its 2.625% Convertible Senior Notes Due 2024 and Shares of its Common Stock

  The Company anticipates that the settlement of the transactions under the exchange agreements will occur on or about December 1, 2017, subject to satisfaction of customary closing conditions.

  November 16, 2017

   · 

  6 min read
• FDA

  GlaxoSmithKline’s Trelegy Ellipta Once-Daily Single Inhaler Triple Therapy Gains Marketing Authorisation in Europe for the Treatment of COPD

  Trelegy Ellipta is the first once-daily single inhaler triple therapy to be approved in Europe.

  November 16, 2017

   · 

  11 min read
• Business

  Golden Meditech and GE Healthcare Team Up to Develop Safe and Efficient Cord Blood Storage Services

  Pursuant to the collaboration, GE Healthcare will provide an integrated and automated digital system and solutions to the Group’s umbilical cord blood cryopreservation processes, aiming to provide efficient storage services to customers at large.

  November 16, 2017

   · 

  2 min read
• Policy

  Alkermes’ NDA for Investigational Product Designed for Initiation Onto ARISTADA Accepted for Filing by U.S. FDA

  FDA action is expected by June 30, 2018.

  November 16, 2017

   · 

  12 min read
• Business

  Edico Genome Partners With Children’s Hospital Los Angeles to Accelerate Diagnoses, Enhance Somatic and Germline Research Initiatives With DRAGEN Bio-IT Platform

  Today at the AMP 2017 Annual Meeting, Edico Genome announced an affiliation with Children’s Hospital Los Angeles.

  November 16, 2017

   · 

  3 min read